Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Robert DeHaven who wrote (426)	6/3/1998 6:29:00 PM
From: Don Hurst	Read Replies (1) \| Respond to of 1510

Well this VaxGen vaccine has certainly got the TV press's attention today. CNBC has been talking it up all afternoon and I just saw a clip that included a guy from CIBC Oppenheimer that mentioned IMNR and it's vaccine in the past tense. Jim Lehrer on the PBS News Hour just said that this VaxGen test was the first one ever to be done on humans. Does IMNR have anyone in PR? They need some publicity. Maybe Remune is past tense. Regards, Don

To: Robert DeHaven who wrote (426)	6/3/1998 6:53:00 PM
From: Manny Gugliuzza	Respond to of 1510

ALL************************************** what i find most encouraging of all the recent new stages of development for H I V therapies is that REMUNE has or been chosen to qualify itself with and against the most effective therapy allowed buy the FDA to date, the triple combo drugs. and where are most of these other companies in their phaseIII? just entering the tunnel?! where are we comparatively? near the end!! did you know the FD@#@'# A held up the approval of human LYME vaccine after the successful completion of phaseIII due to lack of follow up booster vaccine studies. REMUNE as a therapy will receive earlier approval in combination studies with the triple drugs possibly after this PHASE II in september. a phase III is not need with these triple drugs!!! REMUNE alone will be completed in MARCH for PHASE III and hopefully achieve vaccine status soon after. this sharp up swing ongoing now shows a lot of support from the 11$ high points of the previous reverse head and shoulder we came out of. checking the weekly chart again smooths out all these rough edges and the support areas are more evident. could get a sharp snap up just like we came down if support continues above 50 day MA. very bullish here. ar